Entero Healthcare Solutions has reported its audited financial results for the quarter and financial year ended March 31, 2026. The company achieved a consolidated annual revenue of ₹65,912.12 million and a net profit of ₹1,458.40 million. Alongside these robust financial results, the company announced the strategic acquisition of Vishal Surgicals and Vishal Surgicals & Medicals to strengthen its distribution network, and confirmed the date for its 8th Annual General Meeting for August 19, 2026.
Annual and Quarterly Financial Highlights
For the financial year ended March 31, 2026, Entero Healthcare Solutions reported a strong consolidated revenue of ₹65,912.12 million, compared to ₹50,957.80 million in the previous year. The annual consolidated net profit reached ₹1,458.40 million. For the quarter ended March 31, 2026 (Q4), the company recorded a consolidated revenue of ₹19,099.27 million and a net profit of ₹451.28 million.
Strategic Business Expansion
The company announced the acquisition of Vishal Surgicals and Vishal Surgicals & Medicals, a partnership firm, through its subsidiary, Sai Pharma Distributors Private Limited. This acquisition is a business transfer deal valued at up to ₹92.1 million, aimed at enhancing the company’s presence in the wholesale distribution of pharmaceutical and surgical products. The transaction is expected to be completed by December 31, 2026.
Board and Corporate Updates
The Board of Directors has approved the re-appointment of Mr. Sujesh Vasudevan, Mr. Rajesh Shashikant Dalal, and Ms. Sandhya Gadkari Sharma as Independent Directors for a second term of five years, effective from August 25, 2026. Additionally, the company has scheduled its 8th Annual General Meeting to be held on Wednesday, August 19, 2026, via video conferencing.
Employee Stock Option Plan
In a move to incentivize its workforce, the company approved the allotment of 7,240 equity shares upon the exercise of vested options under the Entero Employee Stock Option Plan 2023. Furthermore, the Board noted the grant of 7,300 fresh employee stock options to eligible employees, reflecting a continued commitment to employee participation in the company’s growth.
Source: BSE
